Artificial Intelligence

Artificial intelligence (AI) is becoming a crucial component of healthcare to help augment physicians and make them more efficient. In medical imaging, it is helping radiologists more efficiently manage PACS worklists, enable structured reporting, auto detect injuries and diseases, and to pull in relevant prior exams and patient data. In cardiology, AI is helping automate tasks and measurements on imaging and in reporting systems, guides novice echo users to improve imaging and accuracy, and can risk stratify patients. AI includes deep learning algorithms, machine learning, computer-aided detection (CAD) systems, and convolutional neural networks. 

Delivering value

The onus on imaging in general and advanced visualization specifically is to demonstrate value to the patient and the physician.

JAMIA: Decision support tools efficacious in CRC screening

A study of personalized decision support (PDS) showed improvements to people's attitudes and beliefs about colorectal cancer (CRC) screening, increasing the likelihood they would engage in future CRC screening.

Mobile Devices Expand Radiologists Horizons

Can mobile devices untether radiologists? Evidence is building that these platforms will improve patient care, efficiency and communication in radiology.

AAMI gives its new nonprofit safety council $500K

AAMIs Healthcare Technology Safety Council, an arm of the nonprofit AAMI Foundation, has received a $500,000 gift from the parent organization.

Levick named first CMIO at Lehigh

Donald L. Levick, MD, MBA, was recently named the first CMIO at Lehigh Valley Health Network in Allentown, Pa.

Advanced viz makes its case

Advanced visualization technology continues to advance, as confirmed by a host of current superusers from neuroradiologists to cardiologists to surgeons. The technology, however, may be constrained by the current fiscal climate, which is clamping down on bundled codes used for many studies that leverage advanced visualization. The onus may be on the technology to demonstrate improved efficiency and better patient outcomes.

The Utilization Slowdown: CDS & RBMs

Nationwide trends show imaging utilization has flattened, and yet scrutiny over the appropriate use of imaging is just gearing up. With pressure on physicians growing, two chief mechanisms for driving appropriate use are coming to the foreclinical decision support (CDS) and radiology benefits managers (RBMs).

Miller to advise i2 Initiative

Holly Miller, MD, MBA, chief medical officer of MedAllies and vice chair of the HIMSS board of directors, will serve on the advisory board for the Investing in Innovations (i2) Initiative, an Office of the National Coordinator for Health Information (ONC) program designed to spur innovations in health IT.

Around the web

Harvard’s David A. Rosman, MD, MBA, explains how moving imaging outside of hospitals could save billions of dollars for U.S. healthcare.

Back in September, the FDA approved GE HealthCare’s new PET radiotracer, flurpiridaz F-18, for patients with known or suspected CAD. It is seen by many in the industry as a major step forward in patient care. 

After three years of intermittent shortages of nuclear imaging tracer technetium-99m pyrophosphate, there are no signs of the shortage abating.